"Dear Doctor - Participate in this fun and exciting Use of Itraconazole in Gynecology. Itraconazole (brand name Sporanox) is an antifungal medication that is used to treat certain fungal infections. These include candidiasis (yeast infection), as well as more serious infections such as histoplasmosis and Blastomyces dermatitidis infections. Itraconazole can also be used to prevent fungal infections in people who are at high risk of developing them, such as those with weakened immune systems or who have undergone organ transplantation. The drug works by preventing the fungus from growing and multiplying. Itraconazole is available in both oral and intravenous (IV) forms. The oral form is usually taken once or twice daily, while the IV form is given every 12 hours. Common side effects of itraconazole include headache, nausea, vomiting, diarrhea, and abdominal pain. Participate Now."
1.
Charles III, King of Kings, is Cancerous.
2.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
3.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
4.
Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
2.
Ultimate Guide to Oncology Services in the USA
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
5.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
Recommended News For You
1.
Liver cancer survival rates reflect income disparities
2.
According to research, the mineralization of the bone matrix controls the growth of tumor cells.
3.
Significant differences in breast cancer care still exist, but surgeons can change.
4.
AI catches one-third of interval breast cancers missed at screening
5.
The diamonds that could find cancer
Conferences That Might Interest You
Recommended Articles For You
1.
Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence
2.
Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health
3.
Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology
4.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
5.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation